Last reviewed · How we verify

NCT03536702

Effect of Group Led Creative Writing on Mood in Cancer Patients

Completed NA Results posted Last updated 20 October 2020
What this trial tests

NA trial testing Creative Writing Workshop in Cancer Patients in 60 participants. Completed in 16 November 2018.

Timeline
28 March 2018
Primary endpoint
16 November 2018
16 November 2018

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment60
Start date28 March 2018
Primary completion16 November 2018
Estimated completion16 November 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

20 and older, any sex, with Cancer Patients. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Emotional Thermometer Subscale 1- Distress at Final Primary · 4 months

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

GroupValue95% CI
Creative Writing Workshop00 – 4
Independent Writing - Control Group1.50 – 4.5
Emotional Thermometer Subscale 2 - Anxiety at Final Primary · 4 months

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

GroupValue95% CI
Creative Writing Workshop10 – 6
Independent Writing - Control Group2.51 – 7
Emotional Thermometer Subscale 3 - Depression at Final Primary · 4 months

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.re.

GroupValue95% CI
Creative Writing Workshop00 – 6
Independent Writing - Control Group20 – 7
Emotional Thermometer Subscale 4-anger at Final Primary · 4 months

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score..

GroupValue95% CI
Creative Writing Workshop00 – 4
Independent Writing - Control Group1.50 – 5
Emotional Thermometer Subscale 5-need Help at Final Primary · 4 months

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.

GroupValue95% CI
Creative Writing Workshop00 – 6
Independent Writing - Control Group0.50 – 3
Emotional Thermometer Score (Total) at Final Primary · 4 months

Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.score.

GroupValue95% CI
Creative Writing Workshop20 – 25
Independent Writing - Control Group9.52 – 21
Depression Symptoms Secondary · 4 months

Severity of depression symptoms before and after intervention between two groups. The validated depression questionnaire, the Patient Health Questionnaire-9 (PHQ-9), will be used to predict changes. This questionnaire includes 9 questions, that describes individual symptoms of depression and asks individuals to asses how much each depression symptoms has bothered them in the last two weeks, from 0 (not at all) to 3 (nearly every day). The total score is compiled to represent a final depression severity score, with higher scores indicating worse severity, at a maximum value of 27 points.

GroupValue95% CI
Creative Writing Workshop30 – 18
Independent Writing - Control Group31 – 16
Self Reported Somatic Symptoms at Final Secondary · 4 months

Self-reported somatic symptoms pre and post intervention in two groups. We will use the Somatic Symptom Scale - 8 (SSS-8) to quantify somatic symptom burden. The scale is composed of 8 questions with options to choose a score of 0 (not at all) - 4 (very much) to describe degree of distress caused by individual somatic symptoms. A total of the 8 scores is used as a final value for the SSS-8, with higher scores indicating worse Somatic Symptom severity.

GroupValue95% CI
Creative Writing Workshop71 – 16
Independent Writing - Control Group51 – 20
Depression Symptoms at Final Secondary · 4 months

Severity of depression symptoms before and after intervention between two groups. The validated depression questionnaire, the Patient Health Questionnaire-9 (PHQ-9), will be used to predict changes. This questionnaire includes 9 questions, that describes individual symptoms of depression and asks individuals to asses how much each depression symptoms has bothered them in the last two weeks, from 0 (not at all) to 3 (nearly every day). The total score is compiled to represent a final depression severity score, with higher scores indicating worse severity, at a maximum value of 27 points

GroupValue95% CI
Creative Writing Workshop30 – 18
Independent Writing - Control Group31 – 16
Status of Cancer at Consent Secondary · consent

Comparison of status of cancer (stable, progressing, in remission) between intervention and control group.

Cured
GroupValue95% CI
Creative Writing Workshop2
Independent Writing - Control Group1
New
GroupValue95% CI
Creative Writing Workshop10
Independent Writing - Control Group2
Progression
GroupValue95% CI
Creative Writing Workshop5
Independent Writing - Control Group0
Stable
GroupValue95% CI
Creative Writing Workshop9
Independent Writing - Control Group5
Number of Subjects Who Were Admitted to the Hospital and ER Admissions During Study Time Secondary · 4 months

Difference in number of emergency room visits and hospitalizations during study period between control and intervention group

GroupValue95% CI
Creative Writing Workshop5
Independent Writing - Control Group0
Number of Subject That Were Not Hospital or ER Admissions After Study Secondary · 4 months

Difference in number of emergency room visits and hospitalizations during study period between control and intervention group

GroupValue95% CI
Creative Writing Workshop20
Independent Writing - Control Group4

Sponsor's own description

The primary purpose of this study is to determine whether creative writing in newly diagnosed cancer patients and those with recent progression in their disease will have a positive impact on their mental health. Using a randomized controlled trial approach, emotion thermometers will be employed to evaluate participants' responses on a number of domains, such as anxiety, depression, despair, and anger along with a series of survey questions to monitor changes in depressive and anxiety symptoms. Open-ended survey questions will be used to capture how a creative writing intervention impacts participants' experience of their illness. Melissa Greene's Write from the Heart program focuses more on creative writing rather than cancer focused topics. Patients in the intervention arm will complete -one and a half hour group sessions every two weeks over the span of 3 months. Participants in the active control arm will be provided a book (i.e., Writing Down Bones by Natalie Goldberg) about creative writing and will be asked to do activities for 1.5 hrs every 2 weeks for a period of 3 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer Patients

Currently open trials in the same condition.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03536702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing